WallStreetZenWallStreetZen

NASDAQ: GROW
U S Global Investors Inc Stock

$2.59-0.06 (-2.26%)
Updated Mar 4, 2024
GROW Price
$2.59
Fair Value Price
$3.40
Market Cap
$36.59M
52 Week Low
$2.41
52 Week High
$3.30
P/E
11.26x
P/B
0.72x
P/S
3.13x
PEG
N/A
Dividend Yield
3.47%
Revenue
$12.89M
Earnings
$3.23M
Gross Margin
100%
Operating Margin
32.89%
Profit Margin
25%
Debt to Equity
0.05
Operating Cash Flow
$3M
Beta
0.67
Next Earnings
N/A
Ex-Dividend
Mar 8, 2024
Next Dividend
Mar 25, 2024

GROW Overview

U.S. Global Investors, Inc. is a publicly owned investment manager. The firm primarily provides its services to investment companies. It also provides its services to pooled investment vehicles. The firm manages equity and fixed income mutual funds for its clients. It also manages hedge funds. The firm also manages exchange traded funds. It invests in the public equity and fixed income markets across the globe. It invests in G.A.R.P. and value stocks to make its equity investments. The firm employs a fundamental and quantitative analysis with top-down and bottom-up stock picking approach to make its investments. U.S. Global Investors, Inc. was founded in 1968 and is based in San Antonio, Texas.

Zen Score

Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GROW scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GROW ($2.59) is undervalued by 23.83% relative to our estimate of its Fair Value price of $3.40 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GROW ($2.59) is significantly undervalued by 23.83% relative to our estimate of its Fair Value price of $3.40 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
GROW was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more GROW due diligence checks available for Premium users.

Be the first to know about important GROW news, forecast changes, insider trades & much more!

GROW News

Valuation

GROW fair value

Fair Value of GROW stock based on Discounted Cash Flow (DCF)
Price
$2.59
Fair Value
$3.40
Undervalued by
23.83%
GROW ($2.59) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GROW ($2.59) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GROW was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GROW price to earnings (PE)

For valuing profitable companies with steady earnings
Company
11.26x
Industry
-126.58x
Market
36.03x
GROW is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GROW is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

GROW price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
2.39x
GROW is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GROW's financial health

Profit margin

Revenue
$2.8M
Net Income
$1.2M
Profit Margin
43.6%
GROW's Earnings (EBIT) of $4.24M... subscribe to Premium to read more.
Interest Coverage Financials
GROW's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$53.6M
Liabilities
$2.7M
Debt to equity
0.05
GROW's short-term assets ($40.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GROW's short-term assets ($40.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GROW's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GROW's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$26.0k
Investing
$1.5M
Financing
-$873.0k
GROW's operating cash flow ($2.69M)... subscribe to Premium to read more.
Debt Coverage Financials

GROW vs Asset Management Stocks

TickerMarket Cap1d %P/EP/B
GROW$36.59M-2.26%11.26x0.72x
RAND$35.81M+0.92%6.19x0.58x
HYW$31.99M0.00%2.11x0.21x
MGLD$41.67M+1.73%-35.27x1.44x
BENF$30.12M-0.91%-0.01x-0.17x

U S Global Investors Stock FAQ

What is U S Global Investors's quote symbol?

(NASDAQ: GROW) U S Global Investors trades on the NASDAQ under the ticker symbol GROW. U S Global Investors stock quotes can also be displayed as NASDAQ: GROW.

If you're new to stock investing, here's how to buy U S Global Investors stock.

What is the 52 week high and low for U S Global Investors (NASDAQ: GROW)?

(NASDAQ: GROW) U S Global Investors's 52-week high was $3.30, and its 52-week low was $2.41. It is currently -21.52% from its 52-week high and 7.47% from its 52-week low.

How much is U S Global Investors stock worth today?

(NASDAQ: GROW) U S Global Investors currently has 14,127,529 outstanding shares. With U S Global Investors stock trading at $2.59 per share, the total value of U S Global Investors stock (market capitalization) is $36.59M.

U S Global Investors stock was originally listed at a price of $0.94 in Dec 31, 1997. If you had invested in U S Global Investors stock at $0.94, your return over the last 26 years would have been 176.12%, for an annualized return of 3.98% (not including any dividends or dividend reinvestments).

How much is U S Global Investors's stock price per share?

(NASDAQ: GROW) U S Global Investors stock price per share is $2.59 today (as of Mar 4, 2024).

What is U S Global Investors's Market Cap?

(NASDAQ: GROW) U S Global Investors's market cap is $36.59M, as of Mar 5, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

U S Global Investors's market cap is calculated by multiplying GROW's current stock price of $2.59 by GROW's total outstanding shares of 14,127,529.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.